You just read:

EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38α Kinase Inhibitor Neflamapimod on the Neurodegenerative Process

News provided by

EIP Pharma, Inc.

Jul 17, 2019, 07:00 ET